Zhangzhou Pientzehuang Pharmaceutical Co Ltd banner

Wall St Price Targets

Price Forecast
Based on 8 analysts

+31% Upside
from ¥127 today

Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436)’s 12-month stock price forecast through November 2027 has a consensus target of ¥166.95, implying 31% upside. The forecast is based on price targets from 8 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Zhangzhou Pientzehuang Pharmaceutical Co Ltd yet.

Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's stock price target?
Price Target
166.95 CNY

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 166.95 CNY with a low forecast of 107.57 CNY and a high forecast of 231.96 CNY.

What is the Revenue forecast for Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Projected CAGR
-1%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is -1%.

What is the Operating Income forecast for Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 10%.

What is the Pre-Tax Income forecast for Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 8%.

What is the Net Income forecast for Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 8%.

Back to Top